Lysophosphatidic acid increases the production of pivotal mediators of decidualization and vascularization in the rat uterus

Placenta. 2013 Sep;34(9):751-6. doi: 10.1016/j.placenta.2013.06.001. Epub 2013 Jun 20.

Abstract

Introduction: The decidual reaction and the formation of new vessels in the uterus are two crucial processes during embryo implantation. Previously, we observed that lysophosphatidic acid (LPA) increases cyclooxygenase-2 derived - prostaglandin E2 production during implantation in the rat uterus and that it augments the expression of decidualization (IGFBP-1) and vascularization (IL-10) markers. Both cyclooxygenase and nitric oxide synthase (NOS) are known enzymes involved in these processes. Thus, we became interested in studying which factors contribute to LPA receptor-specific role during the decidual and the vascular reaction at implantation.

Methods: We adopted a pharmacological approach in vitro incubating the uterus from rats on day 5 of gestation (day of implantation) with LPA, DGPP (a highly selective antagonist of LPA3, an LPA receptor) and cyclooxygenase and NOS selective and non-selective inhibitors. We determined NOS activity, prostaglandin E2 production and IGFBP-1 and IL-10 expression to evaluate decidualization and vascularization.

Results: We observed that LPA augmented the activity of the inducible NOS isoform through LPA1/LPA3. Inducible NOS activity participated in the induction of cyclooxygenase-2/prostaglandin E2 increase stimulated by LPA. Also, cyclooxygenase-2 derived prostaglandins mediated LPA-stimulatory action on NOS activity. Both cyclooxygenase-2 and inducible NOS mediated LPA effect on IGFBP-1 and IL-10 expression.

Conclusions: These results suggest the participation of LPA/LPA3 in the production of crucial molecules involved in vascularization and decidualization, two main processes that prepare the uterine milieu for embryo invasion during implantation.

Keywords: Cyclooxygenase-2; Decidualization; Implantation; Inducible nitric oxide synthase; Lysophosphatidic acid; Vascularization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cyclooxygenase 2 / chemistry
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Decidua / blood supply*
  • Decidua / cytology
  • Decidua / drug effects
  • Decidua / metabolism
  • Dinoprostone / metabolism
  • Embryo Implantation* / drug effects
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gene Expression Regulation, Developmental / drug effects
  • Insulin-Like Growth Factor Binding Protein 1 / genetics
  • Insulin-Like Growth Factor Binding Protein 1 / metabolism
  • Interleukin-10 / genetics
  • Interleukin-10 / metabolism
  • Lysophospholipids / antagonists & inhibitors
  • Lysophospholipids / metabolism*
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / metabolism
  • Placentation*
  • Pregnancy
  • Protein Isoforms / antagonists & inhibitors
  • Protein Isoforms / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Lysophosphatidic Acid / antagonists & inhibitors
  • Receptors, Lysophosphatidic Acid / metabolism*
  • Signal Transduction* / drug effects
  • Uterus / blood supply*
  • Uterus / cytology
  • Uterus / drug effects
  • Uterus / metabolism

Substances

  • Biomarkers
  • Cyclooxygenase 2 Inhibitors
  • Enzyme Inhibitors
  • Insulin-Like Growth Factor Binding Protein 1
  • Lysophospholipids
  • Protein Isoforms
  • Receptors, Lysophosphatidic Acid
  • Interleukin-10
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • Dinoprostone
  • lysophosphatidic acid